BioRestorative Therapies, Inc. has announced a stock repurchase program authorized by its Board of Directors, allowing the company to buy back up to $2 million of its common stock until June 16, 2026.

On August 12, 2025, the Board approved a reverse stock split of the Company’s outstanding shares of Common Stock at a ratio of one-for-five (the “Reverse Stock Split”). The Reverse Stock Split is ...

BitMine Immersion Technologies (AMEX:BMNR) has significantly expanded its stock sale capacity, outlining plans to raise up to $24.5 billion to accelerate Ethereum acquisitions. This total includes up ...

Brown-Forman initiated a $400 million share buyback program in early October, but the program may not be an accretive use of capital. The company's growth outlook is concerning; secular trends in ...

Blue Foundry Bancorp has announced its sixth stock repurchase program, authorizing the buyback of up to 1,082,533 shares of its common stock, representing about 5% of its outstanding shares. This ...

Lemonade (NYSE:LMND) said Monday it is in the process of renewing its reinsurance program, having decided to reduce the ceded proportion of its quota share reinsurance from ~55% to ~20%, effective ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Palantir rose after the Pentagon designated its Maven AI platform a program of record, while a new U.K. regulatory trial highlights potential expansion beyond defense into commercial applications.